Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation

Clinical trial NCT05523440 · TERMINATED

Trial details

NCT number: NCT05523440
Sponsor: University of Oklahoma
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Endometrial Carcinoma Recurrent Ovarian Carcinoma ARID1A Gene Mutation

Start date: 2023-02-15
Primary completion: 2025-01-08
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.